233 related articles for article (PubMed ID: 35342388)
1. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer
Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q
Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388
[No Abstract] [Full Text] [Related]
2. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
3. [Xihuang Pills and its main components inhibit PI3K/Akt/mTOR signaling pathways and promote the apoptosis of prostate cancer cells in PC-3 tumor-bearing mice].
Long Y; Wu YR; Guo YM; Luo XJ; Li XF; Huang TT; Huang Z; Liu Z; Chen ZJ; Zhou Q; Tian XF
Zhonghua Nan Ke Xue; 2021 Apr; 27(4):340-346. PubMed ID: 34914218
[TBL] [Abstract][Full Text] [Related]
4. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
5. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
[TBL] [Abstract][Full Text] [Related]
6. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
[TBL] [Abstract][Full Text] [Related]
7. Xihuang Pill Induces Apoptosis of Human Glioblastoma U-87 MG Cells via Targeting ROS-Mediated Akt/mTOR/FOXO1 Pathway.
Shao M; He Z; Yin Z; Ma P; Xiao Q; Song Y; Huang Z; Ma Y; Qiu Y; Zhao A; Zhou T; Wang Q
Evid Based Complement Alternat Med; 2018; 2018():6049498. PubMed ID: 30046342
[TBL] [Abstract][Full Text] [Related]
8. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Xihuang Pills on proliferation and apoptosis of prostate cancer LNCaP cells based on AR/m TOR signaling pathway].
Dai XJ; Long Y; Zou B; Wu LT; Qiu JF; Wu YR; Deng Z; Wang YL; Zhou Q; Tian XF
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4147-4155. PubMed ID: 37802783
[TBL] [Abstract][Full Text] [Related]
10. Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway.
Chen C; Yuan S; Chen X; Xie J; Wei Z
Am J Cancer Res; 2023; 13(4):1347-1362. PubMed ID: 37168335
[TBL] [Abstract][Full Text] [Related]
11. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
12. The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor-Bearing Mice by PI3K/AKT~AP-1 Signaling Pathway.
Li XY; Su L; Jiang YM; Gao WB; Xu CW; Zeng CQ; Song J; Xu Y; Weng WC; Liang WB
Evid Based Complement Alternat Med; 2018; 2018():6714829. PubMed ID: 29849718
[TBL] [Abstract][Full Text] [Related]
13. Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.
You X; Wu Y; Li Q; Sheng W; Zhou Q; Fu W
Front Pharmacol; 2022; 13():895696. PubMed ID: 35847007
[No Abstract] [Full Text] [Related]
14. Exploring the Regulation Mechanism of Xihuang Pill,
Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
[TBL] [Abstract][Full Text] [Related]
15. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics.
Wang J; Zhang Y; Wang Q; Wang L; Zhang P
Evid Based Complement Alternat Med; 2022; 2022():4651432. PubMed ID: 35449823
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.
Yang Y; Guo Y; Luo H; Wang M; Chen F; Cui H; Chen P; Yin Z; Li L; Dai Y; Zeng J; Zhao J
Front Pharmacol; 2023; 14():1164827. PubMed ID: 37081969
[No Abstract] [Full Text] [Related]
18. Combining Network Pharmacology and Experimental Validation to Study the Action and Mechanism of Water extract of Asparagus Against Colorectal Cancer.
Liang H; Li Y; Wang F; Zhao J; Yang X; Wu D; Zhang C; Liu Y; Huang J; Su M; He Z; Liu Y; Wang J; Tang D
Front Pharmacol; 2022; 13():862966. PubMed ID: 35774597
[No Abstract] [Full Text] [Related]
19. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
20. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment.
Wang K; Miao X; Kong F; Huang S; Mo J; Jin C; Zheng Y
Drug Des Devel Ther; 2021; 15():3749-3764. PubMed ID: 34511884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
